<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ilvm</journal-id><journal-title-group><journal-title xml:lang="ru">Нормативно-правовое регулирование в ветеринарии</journal-title><trans-title-group xml:lang="en"><trans-title>Legal regulation in veterinary medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2782-6252</issn><publisher><publisher-name>SpbGUVM Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52419/issn2782-6252.2023.4.189</article-id><article-id custom-type="elpub" pub-id-type="custom">ilvm-698</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БИОХИМИЯ, АНАТОМИЯ, ФИЗИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BIOCHEMISTRY, ANATOMY, PHYSIOLOGY</subject></subj-group></article-categories><title-group><article-title>Влияние интерферона лямбда на генерацию активных форм кислорода в клетках мышей в условиях оксидативного стресса, индуцированного Митомицином С</article-title><trans-title-group xml:lang="en"><trans-title>Effect of interferon lambda on the generation of active oxygen species in mice under conditions of oxidative stress induced by Mitomycin C</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2960-038X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Востроилова</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vostroilova</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Востроилова Г.А., д-р.биол.наук</p></bio><bio xml:lang="en"><p>G.A. Vostroilova, Dr.Habil. in Biological Sciences</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6861-2554</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хохлова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khokhlova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хохлова Н.А., канд.ветеринар.наук.</p></bio><bio xml:lang="en"><p>N.A. Khokhlova, PhD of Veterinary Sciences</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1574-1317</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шабанов</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shabanov</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шабанов Д.И. </p></bio><bio xml:lang="en"><p>D.I. Shabanov</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8561-417X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корчагина</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Korchagina</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Корчагина А.А., канд.ветеринар.наук</p></bio><bio xml:lang="en"><p>A.A. Korchagina, PhD of Veterinary Sciences</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3135-5811</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Морозова</surname><given-names>Д. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Morozova</surname><given-names>D. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Морозова Д.Д. </p></bio><bio xml:lang="en"><p>D.D. Morozova</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5957-1583</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Некрасов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nekrasov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Некрасов А.В. </p></bio><bio xml:lang="en"><p>A.V. Nekrasov</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>All-Russian Research Veterinary Institute of Pathology, Pharmacology and Therapy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>29</day><month>01</month><year>2024</year></pub-date><volume>0</volume><issue>4</issue><fpage>189</fpage><lpage>194</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Востроилова Г.А., Хохлова Н.А., Шабанов Д.И., Корчагина А.А., Морозова Д.Д., Некрасов А.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Востроилова Г.А., Хохлова Н.А., Шабанов Д.И., Корчагина А.А., Морозова Д.Д., Некрасов А.В.</copyright-holder><copyright-holder xml:lang="en">Vostroilova G.A., Khokhlova N.A., Shabanov D.I., Korchagina A.A., Morozova D.D., Nekrasov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ilvm.elpub.ru/jour/article/view/698">https://ilvm.elpub.ru/jour/article/view/698</self-uri><abstract><p>Данное исследование было направлено на изучение влияния рекомбинантного интерферона лямбда (ИФН-λ), видоспецифичного для крупного рогатого скота, на генерацию активных форм кислорода (АФК) в клетках печени и костного мозга мышей в условиях индуцированного митомицином С оксидативного стресса. В эксперименте были использованы самки белых лабораторных мышей, из которых были сформированы четыре группы по 6 животных в каждой: группа негативного контроля (группа I); группа мышей, получавших трехкратную инъекцию ИФН-λ в дозе 0,1 мл/кг (группа II) и мыши, которым помимо ИФН-λ вводили цитотоксический препарат, индуцирующий процессы свободнорадикального окисления, – митомицин С в дозе 10 мг/кг (группа III), а также животные, получавшие только митомицин С (группа IV). Нами была изучена концентрация и жизнеспособность клеточной суспензии, полученной из печени мышей, а также относительное содержание внутриклеточных АФК в клетках печени и костного мозга животных, оцениваемое по интенсивности флуоресценции окисленной формы 2',7'-дихлордигидрофлуоресцеиндиацетата. Концентрация и жизнеспособность клеток в суспензии печени здоровых мышей не изменялась при введении ИФН-λ (группа II), что свидетельствует об отсутствии токсического эффекта ИФН-λ на данные клетки. Выявлено увеличение уровня АФК в исследуемых клетках при введении ИФН-λ мышам группы II (повышение уровня АФК в 1,3 раза в клетках печени и в 2,9 раза в клетках костного мозга относительно мышей группы I) и снижение содержания АФК у мышей в условиях окислительного стресса индуцированного митомицином С (снижение содержания внутриклеточных АФК в 1,9 и 7,2 раза в клетках печени и костного мозга у животных группы III относительно мышей группы IV). Представленные изменения могут выступать свидетельством нормализации ИФН-λ окислительно-восстановительного баланса в организме и, вероятно, проявляться в связи с иммуномодулирующей активностью ИФН-λ.</p></abstract><trans-abstract xml:lang="en"><p>This research was aimed at studying the effect of species-specific recombinant bovine interferon lambda (IFN-λ) on the generation of reactive oxygen species (ROS) in mouse liver and bone marrow cells under conditions of mitomycin Cinduced oxidative stress. The experiment included female white laboratory mice. There were formed four groups of 6 animals each: the negative control group (group I); the group of mice that received a three-fold injection of IFN-λ at a dose of 0.1 ml/kg (group II) and mice that, in addition to IFN-λ, were administered a cytotoxic drug that induced free radical oxidation processes - mitomycin C at a dose of 10 mg/kg (group III), as well as the animals receiving only mitomycin C (group IV). We studied the concentration and viability of a cell suspension obtained from the liver of mice, as well as the relative content of intracellular ROS in the liver and bone marrow cells of animals, assessed by the fluorescence intensity of the oxidized form of 2',7'-dichlorodihydrofluorescein diacetate. The concentration and viability of cells in the liver suspension of healthy mice did not change with the introduction of IFN-λ (group II), indicating the absence of a toxic effect of IFN-λ on these cells. An increase in the level of ROS in the studied cells was detected when IFN-λ was administered to mice of group II (an increase in the level of ROS by 1.3 times in liver cells and by 2.9 times in bone marrow cells, relative to the mice of group I) and a decrease in the level of ROS in the mice under conditions of oxidative stress induced by mitomycin C (reduction in the content of intracellular ROS by 1.9 and 7.2 times in liver and bone marrow cells in the animals of group III, relative to the mice of group IV). The presented changes may indicate the normalization of IFN-λ redox balance in the body and, probably, appear in connection with the immunomodulatory activity of IFN-λ.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>активные формы кислорода</kwd><kwd>интерферон лямбда</kwd><kwd>митомицин С</kwd><kwd>оксидативный стресс</kwd><kwd>лабораторные мыши</kwd></kwd-group><kwd-group xml:lang="en"><kwd>reactive oxygen species</kwd><kwd>interferon lambda</kwd><kwd>mitomycin C</kwd><kwd>oxidative stress</kwd><kwd>laboratory mice</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Пожилова Е.В., Новиков В.Е., Левченкова О.С. Активные формы кислорода в физиологии и патологии клетки. Вестник Смоленской государственной медицинской академии. 2015. №2. С. 13-22.</mixed-citation><mixed-citation xml:lang="en">Pozhilova E.V., Novikov V.E., Levchenkova O.S. Reactive oxygen species in cell physiology and pathology. Bulletin of Smolensk State Medical Academy. 2015. No. 2. P. 13-22. [in Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков В.Е., Левченкова О.С. Митохондриальные мишени для фармакологической регуляции адаптации клетки к воздействию гипоксии. Обзоры по клин. фармакологии и лек. терапии. 2014. Т.12, №2. С. 28-35.</mixed-citation><mixed-citation xml:lang="en">Novikov V.E., Levchenkova O.S. Mitochondrial targets for pharmacological regulation of cell adaptation to hypoxia. Reviews on clinical pharmacology and med. therapy. 2014. V.12, No. 2. P. 28-35. [in Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lukyanova L.D., Sukoyan G.V., Kirova Y.I. Role of proinflammatory factors, nitric oxide, and some parameters of lipid metabolism in the development of immediate adaptation to hypoxia and HIF-1α accumulation. Bull. Exp. Biol. Med. 2013. V.154, N5. P. 597-601.</mixed-citation><mixed-citation xml:lang="en">Lukyanova L.D., Sukoyan G.V., Kirova Y.I. Role of proinflammatory factors, nitric oxide, and some parameters of lipid metabolism in the development of immediate adaptation to hypoxia and HIF-1α accumulation. Bull. Exp. Biol. Med. 2013. V.154, N5. P. 597-601.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Пинегин Б.В., Воробьёва Н.В., Пащенков М.В., Черняк Б.В. Роль митохондриальных активных форм кислорода в активации врожденного иммунитета. Иммунология. 2018. №39(4). 221-229. DOI: 10.18821/0206-4952-2018-39-4-221-229.</mixed-citation><mixed-citation xml:lang="en">Pinegin B.V., Vorobyeva N.V., Pashchenkov M.V., Chernyak B.V. Role of mitochondrial reactive oxygen species in the activation of innate immunity. Immunology. 2018. No. 39(4). 221-229. DOI: 10.18821/0206-4952-2018-39-4-221-229 [in Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rashida Gnanaprakasam J.N., Wu R., Wang R. Metabolic reprogramming in modulating t cell reactive oxygen species generation and antioxidant capacity. Front. Immunol. 2018. Vol. 16, № 9. Р. 1075. DOI: 10.3389/fimmu.2018.01075.</mixed-citation><mixed-citation xml:lang="en">Rashida Gnanaprakasam J.N., Wu R., Wang R. Metabolic reprogramming in modulating t cell reactive oxygen species generation and antioxidant capacity. Front. Immunol. 2018. Vol. 16, No. 9. R. 1075. DOI: 10.3389/fimmu.2018.01075.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Shekhova E. Mitochondrial reactive oxygen species as major effectors of antimicrobial immunity. PLoS Pathog.. 2020. Vol. 16, № 5. Р. 1008470. DOI: 10.1371/journal.ppat.1008470.</mixed-citation><mixed-citation xml:lang="en">Shekhova E. Mitochondrial reactive oxygen species as major effectors of antimicrobial immunity. PLoS Pathog. 2020. Vol. 16, No. 5. R. 1008470. DOI: 10.1371/journal.ppat.1008470.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Скупневский С.В., Пухаева Е.Г., Бадтиев А.К., Руруа Ф.К., Батагова Ф.Э., Фарниева Ж.Г. Особенности развития аутоиммунной патологии в условиях митохондриальной дисфункции у крыс. Инфекция и иммунитет. 2023. Т. 13, № 1. C. 161–166. DOI: 10.15789/2220-7619-TFO-2038</mixed-citation><mixed-citation xml:lang="en">Skupnevskiy S.V., Pukhaeva E.G., Badtiev A.K., Rurua F.K., Batagova F.E., Farnieva Zh.G. Features of the development of autoimmune pathology in conditions of mitochondrial dysfunction in rats. Infection and immunity. 2023. V. 13, No. 1. P. 161–166. DOI: 10.15789/2220-7619-TFO-2038 [in Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Murayama, T., Takahashi, N., Ikoma, N. Cytotoxicity and characteristics of mitomycin C. Ophthalmic Res. 1996. №28(3). Рр. 153-159. DOI: 10.1159/000267896.</mixed-citation><mixed-citation xml:lang="en">Murayama, T., Takahashi, N., Ikoma, N. Cytotoxicity and characteristics of mitomycin C. Ophthalmic Res. 1996. No. 28(3). Рр. 153-159. DOI: 10.1159/000267896.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sinitsky, M.Yu., Kutikhin, A.G., Tsepokina, A.V., Shishkova, D.K., Asanov, M.A., Yuzhalin, A.E., Minina, V.I., Ponasenko, A.V. Mitomycin C induced genotoxic stress in endothelial cells is associated with differential expression of proinflammatory cytokines. Mutat Res. 2020. №858-860. Р.503252. DOI: 10.1016/j.mrgentox.2020.503252.</mixed-citation><mixed-citation xml:lang="en">Sinitsky, M.Yu., Kutikhin, A.G., Tsepokina, A.V., Shishkova, D.K., Asanov, M.A., Yuzhalin, A.E., Minina, V.I., Ponasenko, A.V. Mitomycin C induced genotoxic stress in endothelial cells is associated with differential expression of proinflammatory cytokines. Mutat Res. 2020. No. 858-860. Р.503252. DOI: 10.1016/j.mrgentox.2020.503252.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kumari, S., Naik, P., Vishma, B.L., Salian, S.R., Devkar, R.A., Khan, S., Mutalik, S., Kalthur, G., Adiga, S.K. Mitigating effect of Indian propolis against mitomycin C induced bone marrow toxicity. Cytotechnology. 2016. №68 (5). рр. 1789-17800. DOI: 10.1007/s10616-015-9931-4.</mixed-citation><mixed-citation xml:lang="en">Kumari, S., Naik, P., Vishma, B.L., Salian, S.R., Devkar, R.A., Khan, S., Mutalik, S., Kalthur, G., Adiga, S.K. Mitigating effect of Indian propolis against mitomycin C induced bone marrow toxicity. Cytotechnology. 2016. No. 68 (5). рр. 1789-17800. DOI: 10.1007/s10616-015-9931-4.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Premkumar K., Abraham S.K., Santhiya S.T., Ramesh A. Protective effects of saffron (Crocus sativus Linn.) on genotoxins-induced oxidative stress in Swiss albino mice. Phytother Res. 2003. №17(6). Рр. 614-617. DOI: 10.1002/ptr.1209. PMID: 12820227.</mixed-citation><mixed-citation xml:lang="en">Premkumar K., Abraham S.K., Santhiya S.T., Ramesh A. Protective effects of saffron (Crocus sativus Linn.) on genotoxins-induced oxidative stress in Swiss albino mice. Phytother Res. 2003. No. 17(6). Рр. 614-617. DOI: 10.1002/ptr.1209. PMID: 12820227.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Хохлова Н.А., Востроилова Г. А., Корчагина А. А., Жуков М.С., Шабанов Д.И., Некрасов А.В. Токсикологическое исследование препарата интерферона лямбда при его многократном введении белым крысам. Ветеринарный фармакологический вестник. 2023. № 1(22). С. 31-46. DOI 10.17238/issn2541-8203.2023.1.31</mixed-citation><mixed-citation xml:lang="en">Khokhlova N.A., Vostroilova G.A., Korchagina A.A., Zhukov M.S., Shabanov D.I., Nekrasov A.V. Toxicological study of the interferon lambda preparation at its multiple administration to white rats. Bulletin of Veterinary Pharmacology. 2023. No. 1(22). P. 31-46. DOI 10.17238/issn2541-8203.2023.1.31 [in Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Broggi A, Granucci F, Zanoni I. Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion. Journal of Experimental Medicine. 2020 №217 (1): e20190295. DOI: 10.1084/jem.20190295.</mixed-citation><mixed-citation xml:lang="en">Broggi A, Granucci F, Zanoni I. Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion. Journal of Experimental Medicine. 2020 No. 217 (1): e20190295. DOI: 10.1084/jem.20190295.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по проведению доклинических исследований лекарственных средств. Часть первая. Под ред. А. Н. Миронова. М.: Гриф и К, 2012. 944 с.</mixed-citation><mixed-citation xml:lang="en">Guidelines for conducting preclinical studies of drugs. Part one. Ed. by A. N. Mironov. M.: Grif i K, 2012. 944 p. [in Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Strober W., Trypan Blue Exclusion Test of Cell Viability. Current Protocols in Immunology. 1997. Chapter 21. A.3B.1-A.3B.2. DOI: 10.1002/0471142735.ima03bs21.</mixed-citation><mixed-citation xml:lang="en">Strober W., Trypan Blue Exclusion Test of Cell Viability. Current Protocols in Immunology. 1997. Chapter 21. A.3B.1-A.3B.2. DOI: 10.1002/0471142735.ima03bs21.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Eruslanov E., Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol. 2010. Vol. 594, pp. 57-72.</mixed-citation><mixed-citation xml:lang="en">Eruslanov E., Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol. 2010. Vol. 594, pp. 57-72.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wu X., Zhao Y., Gu Y., Li K., Wang X., Zhang J. Interferon-Lambda 1 Inhibits Staphylococcus aureus Colonization in Human Primary Keratinocytes. Front. Pharmacol. 2021. №12. е652302. DOI: 10.3389/fphar.2021.652302.</mixed-citation><mixed-citation xml:lang="en">Wu X., Zhao Y., Gu Y., Li K., Wang X., Zhang J. Interferon-Lambda 1 Inhibits Staphylococcus aureus Colonization in Human Primary Keratinocytes. Front. Pharmacol. 2021. №12. е652302. DOI: 10.3389/fphar.2021.652302.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Andreakos Е., Zanoni I., Galani I.E., Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control. Current Opinion in Immunology. 2019. Vol. 56. рр. 67-75. DOI: 10.1016/j.coi.2018.10.007.</mixed-citation><mixed-citation xml:lang="en">Andreakos Е., Zanoni I., Galani I.E., Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control. Current Opinion in Immunology. 2019. Vol. 56. рр. 67-75. DOI: 10.1016/j.coi.2018.10.007.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">McGarry T., Biniecka M., Veale D.J., Fearon U. Hypoxia, oxidative stress and inflammation. Free Radic Biol Med. 2018. №125. Рр. 15-24. DOI: 10.1016/j.freeradbiomed.2018.03.042.</mixed-citation><mixed-citation xml:lang="en">McGarry T., Biniecka M., Veale D.J., Fearon U. Hypoxia, oxidative stress and inflammation. Free Radic Biol Med. 2018. No. 125. Рр. 15-24. DOI: 10.1016/j.freeradbiomed.2018.03.042.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Baek S.-H., Park, T., Kang M.-G., Park D. AntiInflammatory activity and ROS regulation effect of sinapaldehyde in LPS-Stimulated RAW 264.7 Macrophages. Molecules. 2020. № 25. Р.4089. DOI: 10.3390/molecules25184089.</mixed-citation><mixed-citation xml:lang="en">Baek S.-H., Park, T., Kang M.-G., Park D. AntiInflammatory activity and ROS regulation effect of sinapaldehyde in LPS-Stimulated RAW 264.7 Macrophages. Molecules. 2020. No. 25. Р.4089. DOI: 10.3390/molecules25184089.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hamblin M.R. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017. №4(3). Рр. 337-361. DOI: 10.3934/biophy.2017.3.337.</mixed-citation><mixed-citation xml:lang="en">Hamblin M.R. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017. No. 4(3). Рр. 337-361. DOI: 10.3934/biophy.2017.3.337.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
